| CML (n= 10) | PV (n= 10) | ET (n= 10) | MF (n= 27) |
---|
SFRP-2 | U | M | U | M | U | M | U | M |
JAK2, wt | 10 | 0 | 1 | 1 | 4 | 1 | 12 | 1 |
JAK2V617F | 0 | 0 | 6 | 2 | 2 | 3 | 8 | 6 |
- CML, chronic myeloid leukemia; ET, essential thrombocythemia; M, methylated; MF, myelofibrosis; PV, polycythemiavera; U, unmethylated; wt = negative for JAK2V617F.